Navigation Links
Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism
Date:11/6/2009

PHILADELPHIA, Nov. 6 /PRNewswire/ -- In a newly-published special supplement, the Journal of Cardiovascular Nursing calls for new hospital policies to prevent and treat venous thromboembolism (VTE), a major cause of death and disability in hospitals throughout the world. Lippincott Williams & Wilkins (LWW) is publishing the supplement to bring attention to VTE, a disease that includes both the common medical condition of deep vein thrombosis and its most serious complication, pulmonary embolism, which accounts for 10% of hospital deaths annually.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

"VTE is a major but often unrecognized cause of morbidity and mortality in hospitalized patients," said Barbara Riegel, DNSc, RN, FAAN, Editor of the Journal of Cardiovascular Nursing and University of Pennsylvania School of Nursing Professor. "Articles in our supplement call for better adherence to current treatment guidelines and hospital-wide education to better prevent and treat deep vein thrombosis and pulmonary embolism."

The supplement provides critical analysis and recommendations on improving the prevention, diagnosis, and treatment of venous thromboembolism.

Articles, and their lead authors, include:

  • Venous Thromboembolism: Commentary on Prevention and Treatment, by Geno J. Merli, MD, FACP, FHM
  • Venous Thromboembolism: A Chronic Illness, by Carol M. Mason, ARNP, CLS, FAHA
  • Pharmacological and Nonpharmacological Interventions for Venous Thromboembolism, by Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA
  • Venous Thromboembolism: What Is Preventing Achievement of Performance Measures and Consensus Guidelines? by Jane Nelson Worel, MS, APRN-BC, APNP

"Nurses in acute care settings, particularly those working in card
'/>"/>

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Hamilton Facial Plastic Surgery is happy ... on July 30th. After months of planning, Dr. Hamilton ... state-of-the-art suite, located only steps away from the original ... one-on-one patient comfort, shorter wait times, and generally a ... new office-suite will continue to provide the same wide ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 DRE Medical ... to announce the launch of its Medical Trade ... resource for medical professionals and equipment vendors. , The ... and conventions in the United States and around the ... calendar, and that number is always growing. , Information ...
(Date:7/30/2014)... The Technology Association of Georgia in ... (B&TA), today issued its final call for applications and ... companies have until August 29th 2014 to be considered ... selected by the Excalibur Judging Committee. Companies selected as ... judges for interviewing process. , The TAG Excalibur ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help consumers ... Quote tool on its website, LTCconsumer.com , announced Nathan ... free and unlimited. , The Instant Quote tool ... age, gender, and state of residence – and delivers a ... enter any contact information to get started). There is no ...
(Date:7/30/2014)... Detroit, MI (PRWEB) July 30, 2014 ... community to celebrate Safety Day from 4 p.m. to ... in Livonia (29580 7 Mile Road, Livonia, MI 48152). ... DeKeyser, free bike helmets, children’s activities, music, snacks and ... for $299,497 to the Children’s Hospital of Michigan Foundation. ...
Breaking Medicine News(10 mins):Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4
... ... it experiences a significant increase in calls in 2009 , ... Belleville, Ill. (Vocus) July 26, 2009 -- Allsup has awarded ... national nonprofit organization,s Information HelpLine, which is experiencing a dramatic increase in calls from individuals ...
... KIGALI, Rwanda (July 27, 2009) Government health officials ... for accreditation of the continent,s medical laboratories, starting a ... U.S. Government believe will be an historic step to ... patients. Just a handful of Africa,s laboratories are ...
... but long-term use raises concerns , SUNDAY, July 26 ... be given to children apparently depends on who you ... have recommended that obese children as young as 8 ... lifestyle changes don,t improve their health. , , But ...
... , , WASHINGTON, July 25 ... Landrieu today made the following comment on the release of the ... on Small Businesses and Their Employees" report: , ... to address concerns of small businesses and healthcare -- the number ...
... 24 Duane Reade Holdings, Inc. announced today that its ... "Issuers"), have amended the terms of their previously announced offers ... Notes due 2010 (the "Floating Rate Notes") (the "FRN Offer") ... "Subordinated Notes" and, together with the Floating Rate Notes, the ...
... could speed repair of ligaments, tendons, study shows , FRIDAY, ... University undergraduates say they have found a way to quickly ... a procedure they believe may help improve healing and prevent ... procedure as part of a contest sponsored by a medical ...
Cached Medicine News:Health News:Allsup Awards Grant to National Alliance on Mental Illness 2Health News:Allsup Awards Grant to National Alliance on Mental Illness 3Health News:Leading health organizations launch new accreditation process for laboratories across Africa 2Health News:Leading health organizations launch new accreditation process for laboratories across Africa 3Health News:Leading health organizations launch new accreditation process for laboratories across Africa 4Health News:Giving Statins to Kids Provokes Debate 2Health News:Giving Statins to Kids Provokes Debate 3Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 2Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 3Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 4Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 5Health News:Coming Soon -- Stem-Cell Surgical Thread? 2
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... July 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: ... into the cannabis testing and education markets, announced today ... and affairs not previously disclosed or, to its knowledge, ... market action. "We have noticed unusual price ... three trading days," said Steve Barbee , CEO ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... 19, 2011 Families of Spinal Muscular Atrophy announced today ... and Drug Administration to commence a Phase I safety study ... being developed for Spinal Muscular Atrophy. FSMA ... stages of drug development, when risk is the highest.  It ...
... PRNewswire / -- Silicon Valley Bank ... companies worldwide, released a study today that ... capital-backed biotech and medical device companies. Based ... of US venture-capital backed companies (60 biotech and 58 ...
Cached Medicine Technology:Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 2Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 3Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: